Exercise Training to Improve PTSD Symptoms and Health in Older Veterans
Exploring the Effects of Exercise Training on PTSD Symptoms and Physical Health in Older Veterans With PTSD
2 other identifiers
interventional
80
1 country
1
Brief Summary
Posttraumatic stress disorder (PTSD) is prevalent among military Veterans and is more than just a psychological condition; PTSD has profound negative impacts on health, function, and quality of life. Older Veterans are the largest patient population served by the Veterans Health Administration (VHA), and many have lived with PTSD for 40+ years. Veterans with PTSD engage in low levels of physical activity and spend much of their time in sedentary activities, adding to their risk of physical disability. The benefits of exercise on mental health and physical well-being in older adults are well-substantiated, but the effects of exercise training on late-life PTSD symptoms is a new area of study. This study is designed to examine the effects of 6 months of supervised exercise training on PTSD symptoms and PTSD-related conditions (e.g., functional impairment, sleep) in 188 older Veterans with PTSD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2019
CompletedFirst Posted
Study publicly available on registry
December 13, 2019
CompletedStudy Start
First participant enrolled
June 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedResults Posted
Study results publicly available
March 25, 2026
CompletedMarch 25, 2026
March 1, 2026
3.7 years
December 11, 2019
February 11, 2026
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinician-Administered PTSD Scale for DSM-V (CAPS-5) Change Baseline to 6 Months
PTSD symptoms over the previous month will be assessed with the CAPS-5 clinical interview. Total symptom severity score and symptom cluster severity scores will be calculated. Scores range from 0 to 80, with higher scores reflecting more severe PTSD symptoms.
6 months
Six-minute Walk Test Change From Baseline to 6 Months
Performance-based measure of aerobic endurance. Participants are instructed to walk along a measured course for 6 minutes. The distance walked in 6 minutes is the outcome of this assessment. There is no maximum value for this test, but the minimum value could be 0 (unable to walk any distance).
6 months
Secondary Outcomes (2)
Patient Health Questionnaire (PHQ-9) Change From Baseline to 6 Months
6 months
Pittsburgh Sleep Quality Index (PSQI) Change From Baseline to 6 Months
6 months
Study Arms (2)
Exercise
EXPERIMENTALProgressive, multi-component supervised exercise training group.
Healthy Aging Attention Control
ACTIVE COMPARATORA health education program that addresses topics relevant to older adults.
Interventions
Participants in the HA-ATC group will receive a health education program modeled on the "10 Keys to Healthy Aging" curriculum and the National Council on Aging's "Aging Mastery Program." HA-ATC will include an 8-week face-to-face group program followed by bi-weekly sessions for the remaining 4 months.
A multi-component group exercise intervention that emphasizes functional training. Duration is 6 months, and frequency is 3x per week.
Eligibility Criteria
You may qualify if:
- Veteran status
- registered for care at Durham VA Health Care System (VAHCS)
- live within 50 miles of fitness facility
- meet diagnostic criteria for PTSD as assessed by the CAPS-5
You may not qualify if:
- history of any psychiatric disorder with severe psychotic features in the past 5 years (e.g., bipolar disorder, mania), as indicated by ICD-10 codes F20-F29 (ICD-9 category 298.9)
- prominent suicidal ideation or hospitalization for suicidality in the previous 6 months
- clinically significant: neurological disorder, systemic illness affecting central nervous system (CNS) function, or history of seizure disorder in the past 5 years
- uncontrolled diabetes defined as:
- Abnormal fasting plasma glucose 126 mg/dL, random plasma glucose 200 mg/dL
- no active medications for diabetes management (Metformin, insulin, etc.)
- no clinical notes in the patient's electronic health record (EHR) indicating monitoring by primary care physician (PCP) or Endo for diabetes management)
- end stage liver disease or currently receiving dialysis
- physical disabilities precluding use of exercise equipment (assistive mobility devices acceptable)
- significant cognitive impairment or diagnosis of Alzheimer's Disease or Dementia
- hospitalization or ER visit in the past 6 months for conditions contraindicated for exercise (cardiac event; physical trauma)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Durham VA Medical Center, Durham, NC
Durham, North Carolina, 27705-3875, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Katherine Hall
- Organization
- Durham VA HCS
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine Shepherd Hall, PhD
Durham VA Medical Center, Durham, NC
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2019
First Posted
December 13, 2019
Study Start
June 7, 2021
Primary Completion
February 10, 2025
Study Completion
February 28, 2025
Last Updated
March 25, 2026
Results First Posted
March 25, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be made available immediately following publication. No end date.
- Access Criteria
- Requests for de-identified meta-data will be considered by the PI, under a data-sharing agreement that includes: 1) a commitment to using the data only for research purposes; 2) a commitment to securing data using appropriate digital technology; and 3) a commitment to destroying or returning the data after analyses are complete. Data access will be provided only to qualified researchers, with a methodologically sound proposal, fully consistent with the VA/NIH data sharing policies and applicable laws and regulations.
All of the individual participant data collected during the trial, after de-identification, will be made available. A limited dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. Only de-identified (stripped of 18 HIPAA) and anonymized datasets (void of any identifying code, study or otherwise) will be shared.